Cardiovascular Risk Reduction Strategies in Community Pharmacy Settings Need Real World Angle

Health Quality Council. Many Saskatchewan heart attack patients not on key life-saving medications. Available: www.hqc.sk.ca/portal.jsp?PAwKMZBBBZ9/FpVJuVtIZT-BIzBf0QfLQkUwK4QBZaJv/lsFHkVd8LCt1ssWtuDunjM5VwD6WZjg= (accessed August 13, 2007).

Blackburn DF Dobson RT Blackburn JL Adherence to statins, beta-blockers, and angiotensin converting enzyme inhibitors following a first cardiovascular event: a retrospective cohort study. Can J Cardiol 2005;21:485–8.

Tsuyuki RT Semchuk W Poirier L 2006 Canadian Hypertension Education Program guidelines for the management of hypertension by pharmacists. Can Pharm J 2006;139[Suppl 1]:S11–S13.

Wiedenmayer K Summers RS Mackie CA Developing pharmacy practice: a focus on patient care. Handbook, 2006 ed. World Health Organization and International Pharmaceutical Federation. Available: www.who.int/medicines/publications/WHO_PSM_PAR_2006.5.pdf (accessed June 27, 2006).

Lee JK Grace KA Taylor AJ . Effect of a pharmacy care program on medication adherence and persistence, blood pressure, and low-density lipoprotein cholesterol. A randomized controlled trial. JAMA 2006;296:2563–71.

Wu JYF Leung WYS Chang S Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. BMJ 2006;333:522–7.

Ali F Laurin M-Y Larieviere C The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol 2003;10:101–6.

Chabot I Moisan J Gregoire JP Milot A . Pharmacist intervention program for control of hypertension. Ann Pharmacother 2003;37(9):1186–93.

Bluml BM McKenney JM Cziraky MJ . Pharmaceutical care services and results in project ImPACT: hyperlipidemia. J Am Pharm Assoc 2000;40:157–65.

Semchuk W Taylor J Sulz L Pharmacist Intervention in Risk Reduction study: high-risk cardiac patients. Can Pharm J 2007;140:32–7.

Chapman RH Benner JS Petrilla AA Predictors of adherence with antihypertensive and lipid-lowering therapy. Arch Intern Med 2005;165:1147–52.

Jackevicius CA Mamdani M Tu JV . Adherence with statin therapy in elderly patients with and without acute coronary syndromes. JAMA 2002;288:462–7.

Benner JS Glynn RJ Mogun H Long-term persistence in use of statin therapy in elderly patients. JAMA 2002;288:455–61.

Avorn J Monette J Lacour A Persistence of use of lipid-lowering medications: a cross-national study. JAMA 1998;279: 1458–62.

Joffres MR Ghadirian P Fodor JG Awareness, treatment, and control of hypertension in Canada. Am J Hypertens 1997;10(10):1097–102.

Jencks SF Huff ED Cuerdon T . Change in the quality of care delivered to medicare beneficiaries, 1998–1999 to 2000–2001. JAMA 2003;289:305–12.

Tsuyuki RT Johnson JA Teo KK A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the study of cardiovascular risk intervention by pharmacists (SCRIP). Arch Intern Med 2002;162:1149–55.